1262278-62-5 Usage
Description
(1s,3s)-3-(benzyloxy)cyclobutyl 4-methylbenzenesulfonate is an organic sulfonate ester characterized by a cyclobutane ring with a benzyloxy group at the 3-position and a 4-methylbenzenesulfonate group at the 1-position. (1s,3s)-3-(benzyloxy)cyclobutyl 4-methylbenzenesulfonate is known for its stability and selectivity in organic synthesis, making it a valuable reagent for the formation of cyclic compounds and as a protecting group for alcohols.
Uses
Used in Organic Synthesis:
(1s,3s)-3-(benzyloxy)cyclobutyl 4-methylbenzenesulfonate is used as a reagent for the formation of cyclic compounds due to its structural properties that facilitate selective reactions with other functional groups.
Used as a Protecting Group for Alcohols:
In organic chemistry, this compound serves as a protecting group for alcohols, allowing for selective reactions to occur at other sites within a molecule without affecting the alcohol group.
Used in Pharmaceutical Industry:
(1s,3s)-3-(benzyloxy)cyclobutyl 4-methylbenzenesulfonate is utilized in the pharmaceutical industry for the synthesis of potential drug candidates, leveraging its stability and reactivity to create new and effective medicinal compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1262278-62-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,2,7 and 8 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1262278-62:
(9*1)+(8*2)+(7*6)+(6*2)+(5*2)+(4*7)+(3*8)+(2*6)+(1*2)=155
155 % 10 = 5
So 1262278-62-5 is a valid CAS Registry Number.
1262278-62-5Relevant articles and documents
METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
-
Paragraph 0968, (2021/11/20)
Mutations in oncogenes and tumor suppressors contribute to the development and progression of cancer. The present disclosure describes compounds and methods to recover wild-type function to p53 mutants. The compounds of the present disclosure can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. The disclosed compounds can be used to reduce the progression of cancers that contain a p53 mutation.
SUBSTITUTED 5-CYANOINDOLE COMPOUNDS AND USES THEREOF
-
Paragraph 00188, (2019/01/10)
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1) - mediated diseases or disorders, Formula (I), wherein R1, R2, R3, R4, and R5 are as defined herein.
CYANO-SUBSTITUTED INDOLE COMPOUNDS AND USES THEREOF AS LSD1 INHIBITORS
-
, (2017/09/15)
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1) - mediated diseases or disorders: (I) wherein R1, R2, R3, R4, R5, and R6 are as defined herein.
